A New Variant Chromosomal Translocation t(2;2)(p23;q23) in CD30+/Ki-1+ Anaplastic Large Cell Lymphoma

Leukemia and Lymphoma

Volumn 28, Issue 42130, 1998, Pages 613-616

  Mitev, Lubomir ^a   Christova, Svetlana ^b   Hadjiev, Evgeni ^c   Guenova, Margarita ^d   Oucheva, Radka ^c   Valkov, Ivan ^d   Manolova, Yanka ^e  

^a MILITARY MEDICAL ACADEMY   (Bulgaria)

^b Department of Pathology and Cytopathology ^*  (Bulgaria)

^c MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^d National Center of Haematology and Transfusiology   (Bulgaria)

^e National Oncology Center Bulgaria   (Bulgaria)

Author keywords

Chromosome abnormality; immunophenotyping; non Hodgkin's lymphoma

Indexed keywords

CD30 ANTIGEN;

AGED; ANAPLASTIC CARCINOMA; ARTICLE; CASE REPORT; CHROMOSOME 2P; CHROMOSOME 2Q; CHROMOSOME TRANSLOCATION 2; HUMAN; LARGE CELL LYMPHOMA; MALE; PRIORITY JOURNAL;

AGED; CHROMOSOMES, HUMAN, PAIR 2; HUMANS; KARYOTYPING; LYMPHOMA, LARGE-CELL, KI-1; MALE; TRANSLOCATION, GENETIC;

EID: 0031925077     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199809058372     Document Type: Article

References (15)

1. Kristoffersson U., Heim S., Heldrup J., Akerman M., Garwicz S., Mitelman F. Cytogenetic studies of childhood non-Hodgkin lymphomas. Hereditas 1985; 103: 77 – 84
2. Knuutila S., Lakkala T., Teerenhovi L., Peltomaki P., Kovanen R., Franssila K. t(2;5)(p23;q35)-A specific chromosome abnormality in large cell anaplastic (Ki-1) lymphoma. Leukemia and Lymphoma 1990; 3: 59 – 64
3. Weisenburger D. D., Gordon B. G., Vose J. M., Bast M. A., Chan W. C., Greiner T. C., Anderson J. R., Sanger W. G. Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. Blood 1996; 87: 3860 – 3868
4. Morris S. W., Kristein M. N., Valentine M. B., Dittmer K. G., Shapiro D. N., Saltman D. L., Look A. T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281 – 1284
5. Morgan R., Hecht B. K., Sandberg A. A., Hecht F., Smith S. D. Chromosome 5q35 breakpoint in malignant histiocytosis. New England Journal of Medicine 1986; 312: 1322
6. Soulie J., Rousseau-Merck M. -F., Mouly H., Nezelof C. Cytogenetic study of malignant histiocytosis transplanted into nude mice; presence of translocation between chromosome 5 and 6 and a unique marker (13q+). Virchows Archiv 1986; 50: 339 – 344
7. Rimokh R., Magaud J. -P., Berger F., Samarut J., Coiffier B., Germain D., Mason D. Y. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (‘Ki- lymphoma’). British Journal of Haematology 1989; 71: 31 – 36
8. Tone L. G., Defavery R., Scrideli C. A., Bernardes J. E., Torres F. M., Soares F. A., Peres L. C., Duarte M. H. O. Translocation (I;5)(q32;q35) in CD30+ anaplastic large cell non-Hodgkin lymphoma of childhood-A case report. Cancer Genetics and Cytogenetics 1996; 86: 83 – 86
9. Sainati L., Montaldi A., Stella A., Putti M. C., Zanesco L., Basso G. A novel variant translocation t(2;13)(p23;q34) in Ki-1 large cell anaplastic lymphoma. British Journal of Haematology 1990; 75: 621 – 622
10. Lamant L., Meggetto F., Al Saati T., Brugieres L., de Paillerets B. B., Dastugue N., Bernheim A., Rubie H., Terrier-Lacombe M. J., Robert A., Brousset P., Rigal F., Schlaifer D., Shiota M., Mori S., Delsos G. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 1996; 87: 284 – 291
11. Pileri S. A., Piccaluga A., Poggi S., Sabattini E., Piccaluga P. P., DeVivo A., Falini B., Stein H. Anaplastic large cell lymphoma: update of findings. Leukemia and Lymphoma 1995; 18: 17 – 25
12. Mason D. Y., Bastard C., Rimokh R., Dastugue N., Huret J. -L., Kristoffersson U., Magaud J. -P., Nezelof C., Tilly H., Vannier J. -P., Hemet J., Warnke R. CD30-positive large cell lymphoma (‘Ki-1 lymphoma’) are associated with a chromosomal translocation involving 5q35. British Journal of Haematology 1990; 74: 161 – 168
13. Sandlund J. T., Pui C. H., Roberts W. M., Santana V. M., Morris S. W., Berard C. W., Hutschison R. E., Ribeiro R. C., Mahmoud H., Crist W. M., Heim M., Raimondi S. C. Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35). Blood 1994; 84: 2467 – 2471
14. Slavutsky T., de Vinuesa M. L., Larripa I., Dupont J., de Salum S. B. Translocation (2;3) in hematologic malignancies. Cancer Genetics and Cytogenetics 1986; 21: 335 – 342
15. Bloomfield C. D., Arthur D. C., Frizzera G., Levine E. G., Peterson B. A., Gajl-Peczalska K. J. Nonrandom chromosome abnormalities in lymphoma. Cancer Research 1983; 43: 2975 – 2984